TrialWorld journal of gastroenterology2017

First-week clinical responses to dexlansoprazole 60 mg and esomeprazole 40 mg for the treatment of grades A and B gastroesophageal reflux disease.

Chih-Ming Liang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.